Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry

In conclusion, abrocitinib is an effective treatment for atopic dermatitis and can be effective for patients with previous inadequate response to dupilumab or upadacitinib. Furthermore, hand eczema can improve in patients treated with abrocitinib for atopic dermatitis.PMID:38323500 | PMC:PMC10863496 | DOI:10.2340/actadv.v104.19454

Source: Acta Derm Venereol A... - February 7, 2024 Category: Dermatology Authors: Esm é Kamphuis Celeste M Boesjes Laura Loman Marijke Kamsteeg Inge Haeck Anneke M T Van Lynden-van Nes Klaziena Politiek Liana F Van der Gang Marlies De Graaf Marjolein S De Bruin-Weller Marie L A Schuttelaar Source Type: research